Digital therapeutics is a sub division of digital health which is the combination of innovative technologies, services and products for healthcare and wellness. Digital therapeutics is used separately or in the combination with medical devices, therapies medications are optimized as per the patient care and health outcomes. This technique is used to avoid, cure and manage disease or disorder using software technology. Digital therapeutics utilizes the infrastructure of the internet, machine learning, apps in mobile devices, big data, and artificial intelligence as to embrace personalized therapies. The market is in its early stage and has been growing owing to the realization of integrating digital elements into conventional medical devices. Apart from that, several factors are responsible for growing the traction of digital therapeutics products. Rising healthcare costs have had a vital influence on the growth of the global digital therapeutics market. In past few years, healthcare costs have raised to unsustainable levels resulted in higher costs for drugs and services. That trajectory, boosted by an increase in global elderly population has prompted government and private healthcare industry players to deploy advanced digital therapeutics. Furthermore, the rising penetration of smartphones has brought about a seismic change in the way consumers are accessing healthcare with the help of their smartphones which offers an excellent platform for providing sophisticated digital therapeutics and fuels the growth of the global digital therapeutics market. Additionally, digital therapeutics is being highly leveraged to scale to a huge patient population and to enhance healthcare outcomes. Management of diabetes and other chronic diseases are fields where digital therapeutics has proved its mettle. Other use cases for digital therapeutics are cancer management, pain management, smoking cessation and tougher therapy areas such as Parkinson’s and increase in prevalence of such diseases have propelled the growth of the global market. Unmanageable doctor to patient ratio and the associative affordability of digital therapeutics has been contributing highly to the growth of the global digital therapeutics market.

In addition, the developing economies such as India, China and the Middle East present growth opportunities for digital therapeutics market. In most nations, the market is still in its infancy owing to a dearth of awareness, the minimum availability of these solutions, dearth of IT infrastructure and financial and social constraints. Hence, the dearth of skilled medical practitioners in developing nations highlights the prominence of connected healthcare.

The global Digital Therapeutics Market is segregated on the basis of Application as Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation and Others. Based on End-use the global Digital Therapeutics Market is segmented in Patients, Providers, Payers, Employers and Others.

The global Digital Therapeutics Market report provides geographic analysis covering regions, such as Europe, North America, Asia Pacific, and Rest of The World. The Digital Therapeutics Market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Analysis

Noom, Livongo Health, Omada Health, WellDoc, Pear Therapeutics and others are among the major players in the global Digital Therapeutics Market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

• In April 2021, Welldoc (US) entered into partnership with Dexacom (US). This collaboration helped provide BlueStar with Dexcom G6 CGM as a single platform to people with Type 2 diabetes for enhanced health.
• In March 2021, Pear Therapeutics (US) entered into partnership with Sprectrum Health Systems (US). Tufts Health Plan and Spectrum Health Systems declared collaboration with Pear Therapeutics to test FDA-approved digital therapeutics to assist people with substance use disorders and enhance their recovery journeys by providing solutions for better treatment access.
• In January 2020, Crossroads Treatment Centers (US) entered into partnership with Pear Therapeutics (US) to implement the company’s digital platform reSET-O to support patients with opioid abuse and addiction.

The global Digital Therapeutics Market has been segmented as below:

Digital Therapeutics Market, By Application

• Diabetes
• Obesity
• CVD
• CNS Disease
• Respiratory Diseases
• Smoking Cessation
• Others

Digital Therapeutics Market, By End-use

• Patients
• Providers
• Payers
• Employers
• Others

Digital Therapeutics Market, By Region

• Europe
• North America
• Asia Pacific
• Rest of The World

Digital Therapeutics Market, By Company

• Noom
• Livongo Health
• Omada Health
• WellDoc
• Pear Therapeutics
• Proteus Digital Health
• Propeller Health
• Akili Interactive Labs
• Better Therapeutics
• Happify
• Kaia Health
• Mango Health
• Click Therapeutics
• Canary Health
• Wellthy Therapeutics
• Noom Health Inc.
• 2Morrow Inc.
• Teladoc Health
• FITBIT, INC.
• Medtronic Plc.
• Voluntis, Inc.
  

The report covers the below scope:

• Global Digital Therapeutics Market sizes from 2020 to 2026, along with CAGR for 2020-2026
• Market size comparison for 2019 vs 2026, with actual data for 2019, estimates for 2019 and forecast from 2020 to 2026
• Global Digital Therapeutics Market trends, covering comprehensive range of consumer trends & manufacturer trends
• Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Digital Therapeutics Market
• Major market opportunities and challenges in forecast timeframe to be focused
• Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
• Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

• Base year - 2019
• Estimated year - 2019
• Projected year - 2020
• Forecast period - 2021 to 2026

Report Scope:

The global Digital Therapeutics Market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Digital Therapeutics Market share. Major industry players with significant revenue share include Noom, Livongo Health, Omada Health, WellDoc, Pear Therapeutics and others.

Why to Buy this Report:

• Gain detailed insights on the Digital Therapeutics industry trends
• Find complete analysis on the market status
• Identify the Digital Therapeutics Market opportunities and growth segments
• Analyse competitive dynamics by evaluating business segments & product portfolios
• Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

• The report targeted towards the existing players in the industry is as follows:
• Market Manufacturers/Service Providers
• Market Wholesale/Traders
• Investment and Financial Institutions

Free and Paid Customization based on the requirement